Treatment and Prevention of HIV Infection
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society–USA Panel: https://jamanetwork.com/journals/jama/fullarticle/2799240
- HIV Drug Interactions (University of Liverpool):
www.hiv-druginteractions.org
HIV 101: Initiation of Antiretroviral Therapy and Primary Care for People With HIV
- This webinar is designed for clinicians caring for people with HIV, including residents, infectious diseases fellows, advanced practitioners, and practitioners in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs who are new to the field of HIV patient care. It is also relevant for clinicians who are interested in a review of the field. In the webinar, experts in the field will describe the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV
https://www.iasusa.org/courses/on-demand-webinar-2022-saag-thompson/
HIV 101: Initial Assessment, Initiation of Antiretroviral Therapy, and Monitoring of People With Newly Diagnosed HIV
Presenters: Michael S. Saag, MD, Melanie A. Thompson, MD, and Roger J. Bedimo, MD, MS
November 15, 2023
9:30 AM – 11:00 AM PT
Learning Objectives
On completion of this activity, learners will be able to:
- Describe the pathogenesis of HIV disease and the life cycle of HIV.
- Conduct an initial assessment of a person newly diagnosed with HIV.
- Initiate an appropriate initial antiretroviral therapy regimen in people with HIV according to their clinical presentation and preference.
- Provide appropriate vaccinations for people with HIV, focusing on pneumococcus, hepatitis B, SARS-CoV-2, and mpox according to current guidelines put forth by the Centers for Disease Control and Prevention.
- Maintain continuous monitoring for antiretroviral therapy success and for emergence of comorbid conditions, including cardiovascular disease, renal disease, frailty, etc.
HIV Drug Resistance Mutations
- A current list of mutations associated with clinical resistance to HIV and the accompanying user notes, regularly revised and disseminated by the IAS–USA Drug Resistance Mutations Group.
https://www.iasusa.org/resources/hiv-drug-resistance-mutations/
Create an account with IAS–USA to receive updates on live courses and webinars, drug resistance mutations figures, and the IAS–USA peer-reviewed journal Topics in Antiviral Medicine™.
(Please note: For live, full-day courses, IAS–USA offers a discounted Fellow/Student registration fee)